# PATH-03 Paraguay Feasibility Study

> **NCT07034092** · NA · NOT_YET_RECRUITING · sponsor: **Pathfinder Medical** · enrollment: 20 (estimated)

## Conditions studied

- Kidney Disease, End-Stage

## Interventions

- **DEVICE:** ePATH System will be used to create an endoAVF

## Key facts

- **NCT ID:** NCT07034092
- **Lead sponsor:** Pathfinder Medical
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-10
- **Primary completion:** 2026-06
- **Final completion:** 2026-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2025-07-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07034092

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07034092, "PATH-03 Paraguay Feasibility Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07034092. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*